<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Respir Res</journal-id>
<journal-id journal-id-type="iso-abbrev">Respir. Res</journal-id>
<journal-title-group>
<journal-title>Respiratory Research</journal-title>
</journal-title-group>
<issn pub-type="ppub">1465-9921</issn>
<issn pub-type="epub">1465-993X</issn>
<publisher>
<publisher-name>BioMed Central</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32054482</article-id>
<article-id pub-id-type="pmc">7020588</article-id>
<article-id pub-id-type="publisher-id">1314</article-id>
<article-id pub-id-type="doi">10.1186/s12931-020-1314-5</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Frequent mutation of hypoxia-related genes in persistent pulmonary hypertension of the newborn</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes" equal-contrib="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5989-5377</contrib-id>
<name>
<surname>Wang</surname>
<given-names>Mingbang</given-names>
</name>
<address>
<email>Mingbang.wang.bgi@qq.com</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Zhuang</surname>
<given-names>Deyi</given-names>
</name>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Mei</surname>
<given-names>Mei</given-names>
</name>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ma</surname>
<given-names>Haiyan</given-names>
</name>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Zixiu</given-names>
</name>
<xref ref-type="aff" rid="Aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>He</surname>
<given-names>Fusheng</given-names>
</name>
<xref ref-type="aff" rid="Aff6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cheng</surname>
<given-names>Guoqiang</given-names>
</name>
<xref ref-type="aff" rid="Aff7">7</xref>
<xref ref-type="aff" rid="Aff8">8</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Lin</surname>
<given-names>Guang</given-names>
</name>
<address>
<email>linguang_9999@126.com</email>
</address>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Zhou</surname>
<given-names>Wenhao</given-names>
</name>
<address>
<email>zhouwenhao@fudan.edu.cn</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0407 2968</institution-id><institution-id institution-id-type="GRID">grid.411333.7</institution-id><institution>Shanghai Key Laboratory of Birth Defects, National Health Commision (NHC) Key Laboratory of Neonatal Diseases, Division of Neonatology, National Center for Children’s Health, </institution><institution>Children’s Hospital of Fudan University, </institution></institution-wrap>Shanghai, 201102 China </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0407 2968</institution-id><institution-id institution-id-type="GRID">grid.411333.7</institution-id><institution>Xiamen Key Laboratory of Neonatal Diseases, Neonatal Medical Center, </institution><institution>Xiamen Children’s Hospital, Children’s Hospital of Fudan University (Xiamen Branch), </institution></institution-wrap>Xiamen, 361006 Fujian China </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0407 2968</institution-id><institution-id institution-id-type="GRID">grid.411333.7</institution-id><institution>Division of Pulmonology, </institution><institution>Children’s Hospital of Fudan University, </institution></institution-wrap>Shanghai, 201102 China </aff>
<aff id="Aff4"><label>4</label>Zhuhai Maternal and Children’s Hospital, Zhuhai, 519001 Guangdong China </aff>
<aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0742 0364</institution-id><institution-id institution-id-type="GRID">grid.168645.8</institution-id><institution>Department of Population and Quantitative Health Sciences, </institution><institution>University of Massachusetts Medical School, </institution></institution-wrap>Worcester, MA 01655 USA </aff>
<aff id="Aff6"><label>6</label>Imunobio, Shenzhen, Guangdong China </aff>
<aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0407 2968</institution-id><institution-id institution-id-type="GRID">grid.411333.7</institution-id><institution>Division of Neonatology, </institution><institution>Children’s Hospital of Fudan University, </institution></institution-wrap>Shanghai, 201102 China </aff>
<aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0407 2968</institution-id><institution-id institution-id-type="GRID">grid.411333.7</institution-id><institution>Key Laboratory of Birth Defects, </institution><institution>Children’s Hospital of Fudan University, </institution></institution-wrap>Shanghai, 200436 China </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>13</day>
<month>2</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>13</day>
<month>2</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="ppub">
<year>2020</year>
</pub-date>
<volume>21</volume>
<elocation-id>53</elocation-id>
<history>
<date date-type="received">
<day>18</day>
<month>9</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>4</day>
<month>2</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s). 2020</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<sec>
<title>Aims</title>
<p id="Par1">Persistent pulmonary hypertension of the newborn (PPHN) is characterized by sustained high levels of pulmonary vascular resistance after birth with etiology unclear; Arterial blood oxygen saturation of Tibetan newborns at high latitudes is higher than that of Han newborns at low latitudes, suggesting that genetic adaptation may allow sufficient oxygen to confer Tibetan populations with resistance to pulmonary hypertension; We have previously identified genetic factors related to PPHN through candidate gene sequencing; In this study, we first performed whole exome sequencing in PPHN patients to screen for genetic-related factors.</p>
</sec>
<sec>
<title>Methods and results</title>
<p id="Par2">In this two-phase genetic study, we first sequenced the whole exome of 20 Tibetan PPHN patients and compared it with the published genome sequences of 50 healthy high-altitude Tibetanshypoxia-related genes, a total of 166 PPHN-related variants were found, of which 49% were from 43 hypoxia-related genes; considering many studies have shown that the differences in the genetic background between Tibet and Han are characterized by hypoxia-related genetic polymorphisms, so it is necessary to further verify whether the association between hypoxia-related variants and PPHN is independent of high-altitude life. During the validation phase, 237 hypoxia-related genes were sequenced in another 80 Han PPHN patients living in low altitude areas, including genes at the discovery stage and known hypoxia tolerance, of which 413 variants from 127 of these genes were shown to be significantly associated with PPHN.hypoxia-related genes.</p>
</sec>
<sec>
<title>Conclusions</title>
<p id="Par3">Our results indicates that the association of hypoxia-related genes with PPHN does not depend on high-altitude life, at the same time, 21 rare mutations associated with PPHN were also found, including three rare variants of the tubulin tyrosine ligase-like family member 3 gene (<italic>TTLL3</italic>:p.E317K, <italic>TTLL3</italic>:p.P777S) and the integrin subunit alpha M gene (<italic>ITGAM</italic>:p.E1071D). These novel findings provide important information on the genetic basis of PPHN.</p>
</sec>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>Persistent pulmonary hypertension of the newborn</kwd>
<kwd>Whole exome sequencing</kwd>
<kwd>Target region sequencing</kwd>
<kwd>Hypoxia tolerance</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100010909</institution-id>
<institution>Young Scientists Fund</institution>
</institution-wrap>
</funding-source>
<award-id>No.81701351</award-id>
<principal-award-recipient>
<name>
<surname>Wang</surname>
<given-names>Mingbang</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2020</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Introduction</title>
<p id="Par10">Persistent pulmonary hypertension of the newborn (PPHN) affects 1.9 per thousand live births and is one of the important factors leading to neonatal mortality [<xref ref-type="bibr" rid="CR1">1</xref>], the main feature of patients with PPHN is that pulmonary vascular resistance cannot be rapidly reduced to increase pulmonary blood flow and oxygen levels and to adapt to the postnatal environment [<xref ref-type="bibr" rid="CR2">2</xref>]. Although PPHN can be rapidly diagnosed and treated with vasodilators and life support, the mortality rate remains high, at 8–10%. In surviving patients, PPHN can cause neurological damage, cerebral palsy, deafness, blindness, and other complications [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]. Sustained hypoxia resulting from PPHN has been associated with pulmonary vascular dysfunction, alveolar capillary dysplasia, severe lung dysplasia, and progressive lung injury [<xref ref-type="bibr" rid="CR5">5</xref>]. Epidemiological data also support the association between PPHN and the development of lung disease [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]. Inhaled nitric oxide, a selective pulmonary vasodilator, is widely used in PPHN therapy; however, 30–40% of treated patients, particularly those with pulmonary parenchymal lesions and pulmonary hypoplasia, fail to achieve sustained improvement in oxygenation [<xref ref-type="bibr" rid="CR7">7</xref>]. These findings suggest that there may be a genetic basis for the disease in some PPHN patients.</p>
<p id="Par11">Recent studies have shown that genetic factors play an important role in the pathogenesis of pulmonary arterial hypertension (PAH) [<xref ref-type="bibr" rid="CR8">8</xref>]. However, unlike PAH, PPHN is rarely familial and there has been little research on potential genetic associations [<xref ref-type="bibr" rid="CR2">2</xref>]. We previously used target region sequencing (TRS) of genes associated with vascular activity in PPHN patients, and we found a significant association between the disease and a variant of the <italic>EDN1</italic> endothelin 1-coding gene [<xref ref-type="bibr" rid="CR9">9</xref>], recently, we screened clinically relevant mutations in children with PPHN patients through a target panel containing more than 2700 rare disease-related genes [<xref ref-type="bibr" rid="CR10">10</xref>]. Niermeyer et al. found that the arterial oxygen saturation at birth and in the first 4 months after birth in Tibet (3658 m above sea level) was higher than that in Han newborns at plain, suggesting that genetic adaptation may allow sufficient oxygen to confer resistance to pulmonary hypertension [<xref ref-type="bibr" rid="CR11">11</xref>]; at the same time, recent genome-wide studies have found that genetic basis of Tibetan population adapts to high-altitude chronic hypoxia, hypoxia-inducible factor pathway gene polymorphisms are significantly different among Tibetans and Han population [<xref ref-type="bibr" rid="CR12">12</xref>].</p>
<p id="Par12">In the present study, we sought to extend this study by screening for gene variants associated with PPHN in the high altitudes Tibetan population, which exhibits high adaptability to hypoxia and confers resistance to pulmonary hypertension. We first performed whole exome sequencing (WES) of 20 Tibetan PPHN patients and compared the results with a published dataset of 50 healthy Tibetan individuals to find PPHN-related single nucleotide polymorphisms (SNPs). We then validated in 80 patients from plain PPHN populations to see if the PPHN-related SNPs were independent of high altitudes.</p>
</sec>
<sec id="Sec2">
<title>Materials and methods</title>
<sec id="Sec3">
<title>Patients</title>
<p id="Par13">The high altitudes PPHN patients were recruited from Lhasa People’s Hospital, and the plain PPHN patients were recruited from Children’s Hospital of Fudan University. PPHN was diagnosed by clinical and echocardiographic data, as detailed in our previous study [<xref ref-type="bibr" rid="CR9">9</xref>]. Informed consent was obtained from a parent, and the study was approved by the ethics committee of the Children’s Hospital of Fudan University (No. 2015–169).</p>
</sec>
<sec id="Sec4">
<title>Whole exome and targeted region sequencing</title>
<p id="Par14">Genomic DNA was extracted from patient peripheral blood (1–2 ml) samples using a Magbind Blood DNA Kit (CW Biotech, Beijing, China) according to the manufacturer’s instructions and was stored at − 20 °C. WES and TRS were performed as previously described [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. In brief, whole exomes were captured using SeqCap EZ Exome (44 M) arrays (Roche, Basel, Switzerland). The targeted region was captured using a SeqCap Target Enrichment Kit (Roche) and sequenced using an Illumina HiSeq 2500 System (Illumina, San Diego, CA, USA) at BGI-Shenzhen (BGI, Shenzhen, China).</p>
</sec>
<sec id="Sec5">
<title>Bioinformatics and statistical analysis</title>
<sec id="Sec6">
<title>Discovery stage</title>
<p id="Par15">For the case–control differential analysis, the raw WES datasets from 20 Tibetan PPHN patients were the cases and published WES datasets from 50 healthy Tibetan individuals [<xref ref-type="bibr" rid="CR14">14</xref>] were the controls. First, all raw sequencing data were pre-processed using a customized bioinformatics pipeline as described previously [<xref ref-type="bibr" rid="CR15">15</xref>], and clean reads were generated by removing adapters and filtering out low-quality reads with Trimmomatic [<xref ref-type="bibr" rid="CR16">16</xref>]. Clean reads were then aligned to the human reference genome (Hg19) using the BWA-MEM algorithm [<xref ref-type="bibr" rid="CR17">17</xref>] and further visualized using the SplicingViewer software [<xref ref-type="bibr" rid="CR18">18</xref>], variants were called using GATK [<xref ref-type="bibr" rid="CR19">19</xref>], and the variants were functionally annotated using ANNOVAR [<xref ref-type="bibr" rid="CR20">20</xref>]. We then filtered out variants at depths of &lt;20 in the PPHN samples and at depths of &lt;10 in the controls, and Fisher’s exact test was used to determine the difference between PPHN and controls. <italic>P</italic> &lt; 0.001 was considered significant. Genes with PPHN-associated variants were further enriched according to the KEGG pathway database (version 76 [<xref ref-type="bibr" rid="CR21">21</xref>]). <italic>P</italic> values were determined using Fisher’s exact test, and Q values were determined by false-discovery rate correction of the <italic>P</italic> values. Q &lt; 0.05 was considered significant.</p>
</sec>
<sec id="Sec7">
<title>Validation stage</title>
<p id="Par16">To validate the identified PPHN-associated variants in plain population, an additional 80 PPHN patients were sequenced. Variants at depths &lt;20 were filtered out and published 800 healthy controls WES dataset [<xref ref-type="bibr" rid="CR22">22</xref>] were used as controls for differences analysis using Fisher’s exact test (P value no more than 0.05 were considered significant). The association between gene variants and PPHN was predicted using Phenolyzer [<xref ref-type="bibr" rid="CR23">23</xref>]. Non-synonymous variants with allelic frequencies of ≤0.01 in the Exome Aggregation Consortium (ExAC) database were considered potential disease-causing variants.</p>
</sec>
</sec>
</sec>
<sec id="Sec8">
<title>Results</title>
<p id="Par17">A flowchart of the study design is shown in Fig. <xref ref-type="fig" rid="Fig1">1</xref>. Clinical information on the study participants is given in Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Table S1. In the discovery stage, the average sequencing depth for the 20 Tibetan PPHN patients and 50 Tibetan controls were 40× and 20×, respectively. After strictly filtering out variants with no or low-depth coverage (i.e., &lt; 20 and &lt; 10 for PPHN patients and controls, respectively), a total of 2023 variants were identified (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Table S2) and subjected to case–control differential analysis. Using Fisher’s exact test for single-locus association analysis, a total of 166 significant differences were identified (<italic>P</italic> &lt; 0.001, Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Table S3).
<fig id="Fig1"><label>Fig. 1</label><caption><p>Flowchart of the study design. HIF-1 = hypoxia-inducible factor-1; PPHN = persistent pulmonary hypertension of the newborn; SNVs = single nucleotide variants; WES = whole exome sequencing</p></caption><graphic id="MO1" xlink:href="12931_2020_1314_Fig1_HTML"></graphic></fig></p>
<p id="Par18">In a KEGG pathway analysis, we identified eight pathways enriched in genes with PPHN-associated variants (<italic>Q</italic> &lt; 0.05, Table <xref ref-type="table" rid="Tab1">1</xref>). These were Renal cell carcinoma, Salmonella infection, Pathways in cancer, Graft-versus-host disease, HIF-1 (hypoxia-inducible factor 1) signaling pathway, Bladder cancer, Regulation of actin cytoskeleton, and Gap junction. HIF-1 is a transcription factor that controls the expression of numerous hypoxia-related genes and plays a crucial role in cancer biology [<xref ref-type="bibr" rid="CR24">24</xref>]. We found that three of the HIF-1 signaling pathway-associated genes; namely, <italic>EGF</italic>, <italic>EP300,</italic> and <italic>IL6,</italic> were also present in the other seven pathways enriched in PPHN-associated variants (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Table S4). Therefore, we turned our focus to genes in the HIF-1 signaling pathway. Interestingly, 49% (80/166) of the PPHN-associated variants were genes regulated by hypoxia or related to hypoxia tolerance (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Table S5); we refer to these as hypoxia-related genes.
<table-wrap id="Tab1"><label>Table 1</label><caption><p>Pathways enriched in PPHN-Associated gene variants identified in the tibetan population</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Pathway name</th><th>Pathway ID</th><th>PPHN genes (114)</th><th>All genes (17251)</th><th><italic>P</italic> value</th><th>Q value</th></tr></thead><tbody><tr><td>Renal cell carcinoma</td><td>ko05211</td><td>7</td><td>101</td><td>4.71E-06</td><td>0.001</td></tr><tr><td>Salmonella infection</td><td>ko05132</td><td>10</td><td>317</td><td>4.79E-05</td><td>0.005</td></tr><tr><td>Pathways in cancer</td><td>ko05200</td><td>14</td><td>644</td><td>8.85E-05</td><td>0.006</td></tr><tr><td>Graft-versus-host disease</td><td>ko05332</td><td>5</td><td>74</td><td>0.0001293</td><td>0.006</td></tr><tr><td>HIF-1 signaling pathway</td><td>ko04066</td><td>7</td><td>185</td><td>0.0002281</td><td>0.009</td></tr><tr><td>Bladder cancer</td><td>ko05219</td><td>4</td><td>61</td><td>0.0007062</td><td>0.023</td></tr><tr><td>Regulation of actin cytoskeleton</td><td>ko04810</td><td>11</td><td>588</td><td>0.0017709</td><td>0.050</td></tr><tr><td>Gap junction</td><td>ko04540</td><td>5</td><td>135</td><td>0.0020232</td><td>0.050</td></tr></tbody></table><table-wrap-foot><p>Definition of abbreviations: <italic>HIF-1</italic> Hypoxia-inducible factor-1, <italic>PPHN</italic> Persistent pulmonary hypertension of the newborn</p></table-wrap-foot></table-wrap></p>
<p id="Par19">To verify whether the correlation between hypoxia-related associated genes and PPHN is independent of high altitude, we first conducted a systematic literature search and identified 246 hypoxia-related genes (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Table S5), and then designed a capture chip that captures the exon regions of 246 hypoxia-related genes, finally, the targeted region was sequenced in 80 plain PPHN patients with an average depth of 100x. As in the discovery stage, we use strict filtering standards to remove variants with no or low-depth coverage in the controls, and identified a total of 413 variants significantly associated with PPHN (<italic>P</italic> &lt; 0.05, Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Table S6) in 127 of the 246 hypoxia-related genes. Of these 413, only 5% (21) were population-specific variants (<italic>P</italic> &lt; 0.05, Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Table S7) and were not considered rare (minor allele frequency [MAF] &gt; 0.05 in the ExAC database). Most of these variants (20/21) were located in the intronic or exonic regions and did not result in amino acid changes. One missense variant was associated with the <italic>FANCA</italic> (Fanconi anemia complementation group A) gene.</p>
<p id="Par20">Eighteen of the PPHN-associated variants consisted of non-synonymous mutations in 14 genes; <italic>ANP32D, C12orf54, DR1, DUOXA1, FANCA, ITGAM, MBL2, MDH1B, PFKM, PLAU, PTX3, SIPA1L2, TMEM206,</italic> and <italic>TTLL3</italic> (Table <xref ref-type="table" rid="Tab2">2</xref>). Most of these variants (15/18) were not rare (MAF &gt; 0.01) in ExAC. The three rare (MAF &lt; 0.01) variants were two missense mutations in <italic>TTLL3</italic> (tubulin tyrosine ligase-like 3), p.E317K and p.P777S, and one missense mutation in <italic>ITGAM</italic> (integrin subunit alpha M), p.E1071D. Both <italic>TTLL3</italic> and <italic>ITGAM</italic> were predicted to be associated with the PPHN phenotype using Phenolyzer (<italic>P</italic> = 0.002589 and <italic>P</italic> = 0.03325, respectively).
<table-wrap id="Tab2"><label>Table 2</label><caption><p>PPHN-Associated missense variants identified in the han population</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Chr</th><th>Pos</th><th>Ref</th><th>Alt</th><th>Variants</th><th>Gene</th><th>PPHN (MAF)</th><th>Ctrl (MAF)</th><th><italic>P</italic> value</th><th>OR</th><th>MAF<sup>a</sup></th></tr></thead><tbody><tr><td>chr12</td><td>48,866,585</td><td>A</td><td>C</td><td>p.L46F</td><td><italic>ANP32D</italic></td><td>0.604</td><td>0.687</td><td>0.0487</td><td>0.69</td><td>0.187</td></tr><tr><td>chr12</td><td>48,888,594</td><td>C</td><td>T</td><td>p.P86S</td><td><italic>C12orf54</italic></td><td>0.188</td><td>0.12</td><td>0.0265</td><td>1.70</td><td>0.372</td></tr><tr><td>chr1</td><td>93,826,178</td><td>A</td><td>T</td><td>p.E171D</td><td><italic>DR1</italic></td><td>0.052</td><td>0.016</td><td>0.0121</td><td>3.31</td><td>0.092</td></tr><tr><td>chr15</td><td>45,409,732</td><td>C</td><td>G</td><td>p.R433P</td><td><italic>DUOXA1</italic></td><td>0.071</td><td>0.033</td><td>0.0365</td><td>2.28</td><td>0.083</td></tr><tr><td>chr16</td><td>89,857,935</td><td>G</td><td>A</td><td>p.A412V</td><td><italic>FANCA</italic></td><td>0.156</td><td>0.29</td><td>0.0005</td><td>0.45</td><td>0.065</td></tr><tr><td>chr16</td><td>89,805,914</td><td>T</td><td>C</td><td>p.T1328A</td><td><italic>FANCA</italic></td><td>0.156</td><td>0.274</td><td>0.0017</td><td>0.49</td><td>0.031</td></tr><tr><td>chr16</td><td>89,839,766</td><td>G</td><td>C</td><td>p.P643A</td><td><italic>FANCA</italic></td><td>0.182</td><td>0.297</td><td>0.0032</td><td>0.53</td><td>0.025</td></tr><tr><td>chr16</td><td>89,836,323</td><td>C</td><td>T</td><td>p.G809D</td><td><italic>FANCA</italic></td><td>0.968</td><td>0.99</td><td>0.0443</td><td>0.30</td><td>0.467</td></tr><tr><td>chr16</td><td>31,341,863</td><td>G</td><td>C</td><td>p.E477D</td><td><italic>ITGAM</italic></td><td>0.026</td><td>0.005</td><td>0.027</td><td>5.29</td><td>0.001</td></tr><tr><td>chr10</td><td>54,531,235</td><td>C</td><td>T</td><td>p.G54D</td><td><italic>MBL2</italic></td><td>0.13</td><td>0.209</td><td>0.0262</td><td>0.57</td><td>0.139</td></tr><tr><td>chr2</td><td>207,603,221</td><td>T</td><td>C</td><td>p.T515A</td><td><italic>MDH1B</italic></td><td>0.052</td><td>0.021</td><td>0.0475</td><td>2.52</td><td>0.087</td></tr><tr><td>chr12</td><td>48,501,161</td><td>A</td><td>T</td><td>p.H2L</td><td><italic>PFKM</italic></td><td>0.532</td><td>0.621</td><td>0.0473</td><td>0.70</td><td>0.266</td></tr><tr><td>chr10</td><td>75,673,101</td><td>T</td><td>C</td><td>p.L105P</td><td><italic>PLAU</italic></td><td>0.558</td><td>0.682</td><td>0.0038</td><td>0.59</td><td>0.755</td></tr><tr><td>chr3</td><td>157,155,314</td><td>C</td><td>A</td><td>p.A48D</td><td><italic>PTX3</italic></td><td>0.857</td><td>0.775</td><td>0.0234</td><td>1.74</td><td>0.625</td></tr><tr><td>chr1</td><td>232,539,219</td><td>C</td><td>T</td><td>p.G695S</td><td><italic>SIPA1L2</italic></td><td>0.442</td><td>0.544</td><td>0.0218</td><td>0.66</td><td>0.065</td></tr><tr><td>chr1</td><td>212,587,320</td><td>T</td><td>C</td><td>p.N47D</td><td><italic>TMEM206</italic></td><td>0.162</td><td>0.088</td><td>0.0076</td><td>2.02</td><td>0.035</td></tr><tr><td>chr3</td><td>9,876,568</td><td>C</td><td>T</td><td>p.P777S</td><td><italic>TTLL3</italic></td><td>0.026</td><td>0.005</td><td>0.027</td><td>5.29</td><td>0.001</td></tr><tr><td>chr3</td><td>9,860,595</td><td>G</td><td>A</td><td>p.E317K</td><td><italic>TTLL3</italic></td><td>0.006</td><td>0.038</td><td>0.0463</td><td>0.17</td><td>0.001</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>Minor allele frequency (MAF) according to the Exome Aggregation Consortium database. Definition of abbreviations: <italic>Alt</italic> Alteration, <italic>Chr</italic> Chromosome, <italic>Ctrl</italic> Control, <italic>Pos</italic> Position, <italic>OR</italic> Odds ratio, <italic>PPHN</italic> Persistent pulmonary hypertension of the newborn, <italic>Ref</italic> Reference</p></table-wrap-foot></table-wrap></p>
</sec>
<sec id="Sec9">
<title>Discussion</title>
<p id="Par21">In this two-stage study, we first compared WES data from 20 Tibetan PPHN patients and 50 healthy Tibetan controls living at high altitudes and identified 166 PPHN-associated variants, 49% of which were derived from 43 hypoxia-related genes; considering many studies have shown that the differences in the genetic background between Tibet and Han are characterized by hypoxia-related genetic polymorphisms [<xref ref-type="bibr" rid="CR12">12</xref>]; to further verify whether the association of hypoxia-associated variants with PPHN is independent of high altitude life, we performed a targeted validation study of hypoxia-related genes in an additional 80 Han PPHN patients living at low altitudes. Finally, we discovered 413 PPHN-associated variants from 127 hypoxia-related genes in Han population.</p>
<p id="Par22">Significant changes in blood coagulation at high altitudes may predispose individuals to pulmonary hypertension [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR26">26</xref>]. Negi et al. [<xref ref-type="bibr" rid="CR27">27</xref>] conducted a cross-sectional survey of permanent inhabitants in the Spiti Valley at an altitude of 3000 to 4200 m, although no significant correlation was found between altitude and pulmonary hypertension. However, it is still found that the prevalence rate is increasing with the increase of altitude; the data published to date have not been identified in plateau populations as genetic susceptibility to individual pulmonary hypertension [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR29">29</xref>]. Our results indicates that the association of hypoxia-related genes with PPHN does not depend on high-altitude life, at the same time, some rare mutations associated with PPHN were also found.</p>
<p id="Par23">Two rare missense mutations identified in <italic>TTLL3</italic> (p.E317K and p.P777S) were associated with PPHN. TTLL3 catalyzes the ATP-dependent restoration of tyrosine to the C-terminus of α-tubulin, which polymerizes into microtubules [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>]. Microtubule proliferation has been found in the right ventricular myocytes of rats with monocrotaline-induced pulmonary hypertension, accompanied by upregulated expression of α- and β-tubulin [<xref ref-type="bibr" rid="CR32">32</xref>]. The detyrosination/tyrosination cycle of tubulin is important for regulating the mechanical stabilization of long-lived microtubules in cells, and abnormalities in this cycle are involved in the development of hypertension [<xref ref-type="bibr" rid="CR33">33</xref>]. A recent study found that TTLL3 can also ligate various unnatural amino acids to the C-terminus of tubulin [<xref ref-type="bibr" rid="CR34">34</xref>]. The crystal structure of TTLL3 has recently been solved and suggests that TTLL3 can ligate glycine and glutamate to the tubulin C-terminus, a process crucial for the biogenesis and stability of microtubules in cilia, flagella, spindles, neuronal processes, and platelets [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR36">36</xref>]. Glutamylation, the most prevalent post-translational modification of tubulin, stabilizes microtubules and regulates the recruitment and activity of microtubule-interacting proteins [<xref ref-type="bibr" rid="CR37">37</xref>]. Valenstein et al. found that glutamylation was a major regulator of hereditary spastic paraplegia [<xref ref-type="bibr" rid="CR38">38</xref>]. Consistent with the potential importance of microtubule-associated proteins in PPHN, we found significant enrichment of genes associated with regulation of the actin cytoskeleton among the 166 PPHN-associated variants identified in the Tibetan population. These included <italic>TTLL3, EGF</italic>, <italic>GOLGA1</italic>, <italic>KRAS</italic>, <italic>IQGAP1</italic>, <italic>LRRFIP2</italic>, <italic>RB1CC1</italic>, <italic>TEX14</italic>, <italic>GCOM1</italic>, <italic>ARPC4-TTLL3,</italic> and <italic>MYZAP</italic>. Interestingly, Fediuk et al. found that the eicosanoid thromboxane can induce actin polymerization in hypoxic neonatal pulmonary arterial myocytes [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>].</p>
<p id="Par24">Rare missense mutation identified in in <italic>ITGAM</italic> (p.E1071D) was associated with PPHN, <italic>ITGAM</italic> encodes the integrin alpha M chain, also known as Mac-1, CD11b/CD18, or CR3A. Integrins play important roles in cell–cell adhesion by mediating transmembrane connections to the cytoskeleton and activating intracellular signaling pathways. A previous study showed that integrins are differentially regulated in pulmonary artery smooth muscle cells during pulmonary hypertension [<xref ref-type="bibr" rid="CR41">41</xref>]. In addition, pulmonary artery endothelial cells from patients with idiopathic pulmonary hypertension show decreased adhesion to laminin, and loss of interaction between α3 integrins and the tumor promoter APC (adenomatous poliposis coli) promotes endothelial apoptosis in mice and humans [<xref ref-type="bibr" rid="CR42">42</xref>]. Furthermore, a recent study showed that induced pluripotent stem cell-derived endothelial cells from a patient with familial PAH showed reduced adhesion compared with control cells [<xref ref-type="bibr" rid="CR43">43</xref>]. The missense mutation identified in the present study, p.E1071D, lies in the C-terminal domain of <italic>ITGAM</italic>, which may be responsible for recognizing short peptide motifs [<xref ref-type="bibr" rid="CR44">44</xref>] that are involved in integrin–extracellular matrix interactions. This suggests a potential mechanism by which aberrant behavior of the ITGAM variant may contribute to PPHN.</p>
<p id="Par25">Nevertheless, it is unclear how this integrin may be involved in PAH or PPHN or whether the <italic>ITGAM</italic> mutation is protective or a risk factor. Jiang et al. found that platelet-mediated mesenchymal stem cell homing to the lung can reduce monocrotaline-induced rat pulmonary hypertension [<xref ref-type="bibr" rid="CR45">45</xref>]. A recent study showed that ITGAM can regulate thrombosis via interaction with platelet GPIb [<xref ref-type="bibr" rid="CR46">46</xref>], suggesting that it may play a protective function against thrombosis. However, upregulation of integrins may also be associated with the onset of PPHN, as previous studies have shown that integrins αvβ6 and αvβ8 are upregulated in bronchial epithelial cells from patients with systemic sclerosis, a disease often associated with PAH [<xref ref-type="bibr" rid="CR47">47</xref>]. Welschoff et al. found that the tripeptide Arg-Gly-Asp, which inhibits the adhesion of several integrins, can induce relaxation of pulmonary arteries and reduce pulmonary arterial pressure [<xref ref-type="bibr" rid="CR48">48</xref>].</p>
<p id="Par26">PPHN is not a single disease, but a clinical syndrome caused by multiple factors, that may present with different clinical conditions requiring different treatments and with variable outcomes. The PPHN related genetic variants we described could improve the understanding of the pathogenesis of PPHN and, consequently, increase the spectrum of available treatments by targeting hypoxia related gene pathways [<xref ref-type="bibr" rid="CR49">49</xref>, <xref ref-type="bibr" rid="CR50">50</xref>] . Finally our paper may also suggest the feasibility of whole-genome sequencing for the screening of clinically relevant mutations, associated with PPHN.</p>
<p id="Par27">This study has some innovations. To the best of our knowledge, we have performed exome screening for the first time in PPHN patients; we found that hypoxia-related genes are associated with PPHN and are not dependent on high altitudes. It provides a genetic basis for the pathogenesis of PPHN and also provides a target for our PPHN genetic screening in newborns. There are some limitations to our stud<italic>y.</italic> The published Tibetan WES datasets used as controls were of low coverage, and the rigorous filtering may have eliminated Tibetan-specific variants associated with PPHN. Although we have identified three rare missense variants associated with PPHN, further functional studies will be necessary to understand how they contribute to the pathogenesis of PPHN.</p>
</sec>
<sec id="Sec10">
<title>Conclusions</title>
<p id="Par28">We conducted a two-stage genetic study of 100 PPHN patients and identified several hypoxia-associated gene variants that may be associated with PPHN, and the association of hypoxia-associated gene mutations with PPHN does not depend on high altitude life.</p>
</sec>
<sec sec-type="supplementary-material">
<title>Supplementary information</title>
<sec id="Sec11">
<p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="12931_2020_1314_MOESM1_ESM.xlsx"><caption><p><bold>Additional file 1: Table S1.</bold> Clinical information on study participants. <bold>Table S2.</bold> List of 2023 variants used for case–control analysis in Tibetan population. <bold>Table S3.</bold> List of 166 gene variants significantly associated with PPHN (<italic>P</italic> &lt; 0.001) identified in the Tibetan population. <bold>Table S4.</bold> List of pathways enriched in the 166 variants identified in the Tibetan population. <bold>Table S5.</bold> List of 237 hypoxia-related genes studied in the Han population. <bold>Table S6.</bold> List of 413 variants significantly associated with PPHN (<italic>P</italic> &lt; 0.05) identified in the Han population. <bold>Table S7.</bold> List of 21 population-specific variants significantly associated with PPHN (<italic>P</italic> &lt; 0.05).</p></caption></media></supplementary-material>
</p>
</sec>
</sec>
</body>
<back>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item>
<term>ExAC</term>
<def>
<p id="Par4">Exome Aggregation Consortium</p>
</def>
</def-item>
<def-item>
<term>KEGG</term>
<def>
<p id="Par5">Kyoto Encyclopedia of Genes and Genomes</p>
</def>
</def-item>
<def-item>
<term>PAH</term>
<def>
<p id="Par6">Pulmonary arterial hypertension</p>
</def>
</def-item>
<def-item>
<term>PPHN</term>
<def>
<p id="Par7">Persistent pulmonary hypertension of the newborn</p>
</def>
</def-item>
<def-item>
<term>TRS</term>
<def>
<p id="Par8">Target region sequencing</p>
</def>
</def-item>
<def-item>
<term>WES</term>
<def>
<p id="Par9">Whole exome sequencing</p>
</def>
</def-item>
</def-list>
</glossary>
<fn-group>
<fn>
<p>
<bold>Publisher’s Note</bold>
</p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</fn>
<fn>
<p>Mingbang Wang, Deyi Zhuang and Mei Mei contributed equally to this work.</p>
</fn>
</fn-group>
<sec>
<title>Supplementary information</title>
<p><bold>Supplementary information</bold> accompanies this paper at 10.1186/s12931-020-1314-5.</p>
</sec>
<ack>
<title>Acknowledgements</title>
<p>Thanks to Dr. Yulan Lu from Fudan University, and Dr. Jinyu Wu from the Beijing Institute of Life Sciences, Chinese Academy of Sciences for their assistance in information analysis.</p>
</ack>
<notes notes-type="author-contribution">
<title>Authors’ contributions</title>
<p>MW, GL and WZ conceptualized and designed the study, supervised data collection and revised manuscripts, DZ, MM, HM and GC completed sample collection and clinical evaluation, MW drafted manuscripts, reviewed and revised manuscripts, and FH and ZL conducted bioinformatics analysis. All authors read and approved the final manuscript.</p>
</notes>
<notes notes-type="funding-information">
<title>Funding</title>
<p>This project was supported by National Natural Science Foundation of China (Program No. 81701351, No. 81701498 and No.81720108018), Shanghai Municipal Commission of Health and Family Planning (GDEK201701), by Shanghai Municipal Science and Technology Major Project (2018SHZDZX05), and by Super Postdoctoral Program of Fudan University.</p>
</notes>
<notes notes-type="data-availability">
<title>Availability of data and materials</title>
<p>The datasets for this study can be found in the supplemental material, and the raw data can be obtained from the corresponding author under request.</p>
</notes>
<notes>
<title>Ethics approval and consent to participate</title>
<p id="Par29">The study obtained the informed consent of the participant’s guardian, was approved by the Ethics Committee of Children’s Hospital of Fudan University (No. 2015–169), and complied with the Helsinki Declaration.</p>
</notes>
<notes>
<title>Consent for publication</title>
<p id="Par30">All authors agree to publish this manuscript.</p>
</notes>
<notes notes-type="COI-statement">
<title>Competing interests</title>
<p id="Par31">The authors declare that they have no competing interests.</p>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walsh-Sukys</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Tyson</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Wright</surname>
<given-names>LL</given-names>
</name>
<name>
<surname>Bauer</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Korones</surname>
<given-names>SB</given-names>
</name>
<name>
<surname>Stevenson</surname>
<given-names>DK</given-names>
</name>
<name>
<surname>Verter</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Stoll</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Lemons</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Papile</surname>
<given-names>LA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes</article-title>
<source/>Pediatrics
          <year>2000</year>
<volume>105</volume>
<fpage>14</fpage>
<lpage>20</lpage>
<pub-id pub-id-type="doi">10.1542/peds.105.1.14</pub-id>
<pub-id pub-id-type="pmid">10617698</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goncharova</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Gladwin</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Kawut</surname>
<given-names>SM</given-names>
</name>
</person-group>
<article-title>Update in pulmonary vascular diseases 2014</article-title>
<source/>Am J Respir Crit Care Med
          <year>2015</year>
<volume>192</volume>
<fpage>544</fpage>
<lpage>550</lpage>
<pub-id pub-id-type="doi">10.1164/rccm.201504-0829UP</pub-id>
<pub-id pub-id-type="pmid">26561677</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Porta</surname>
<given-names>NF</given-names>
</name>
<name>
<surname>Steinhorn</surname>
<given-names>RH</given-names>
</name>
</person-group>
<article-title>Pulmonary vasodilator therapy in the NICU: inhaled nitric oxide, sildenafil, and other pulmonary vasodilating agents</article-title>
<source/>Clin Perinatol
          <year>2012</year>
<volume>39</volume>
<fpage>149</fpage>
<lpage>164</lpage>
<pub-id pub-id-type="doi">10.1016/j.clp.2011.12.006</pub-id>
<pub-id pub-id-type="pmid">22341543</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Konduri</surname>
<given-names>GG</given-names>
</name>
<name>
<surname>Vohr</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Robertson</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Sokol</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Solimano</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Singer</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ehrenkranz</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Singhal</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Wright</surname>
<given-names>LL</given-names>
</name>
<name>
<surname>Van Meurs</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Early inhaled nitric oxide therapy for term and near-term newborn infants with hypoxic respiratory failure: neurodevelopmental follow-up</article-title>
<source/>J Pediatr
          <year>2007</year>
<volume>150</volume>
<fpage>235</fpage>
<lpage>240</lpage>
<pub-id pub-id-type="doi">10.1016/j.jpeds.2006.11.065</pub-id>
<pub-id pub-id-type="pmid">17307536</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bishop</surname>
<given-names>NB</given-names>
</name>
<name>
<surname>Stankiewicz</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Steinhorn</surname>
<given-names>RH</given-names>
</name>
</person-group>
<article-title>Alveolar capillary dysplasia</article-title>
<source/>Am J Respir Crit Care Med
          <year>2011</year>
<volume>184</volume>
<fpage>172</fpage>
<lpage>179</lpage>
<pub-id pub-id-type="doi">10.1164/rccm.201010-1697CI</pub-id>
<pub-id pub-id-type="pmid">21471096</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weijerman</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>van Furth</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>van der Mooren</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>van Weissenbruch</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Rammeloo</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Broers</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Gemke</surname>
<given-names>RJ</given-names>
</name>
</person-group>
<article-title>Prevalence of congenital heart defects and persistent pulmonary hypertension of the neonate with Down syndrome</article-title>
<source/>Eur J Pediatr
          <year>2010</year>
<volume>169</volume>
<fpage>1195</fpage>
<lpage>1199</lpage>
<pub-id pub-id-type="doi">10.1007/s00431-010-1200-0</pub-id>
<pub-id pub-id-type="pmid">20411274</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gonzalez</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Fabres</surname>
<given-names>J</given-names>
</name>
<name>
<surname>D'Apremont</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Urcelay</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Avaca</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gandolfi</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kattan</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Randomized controlled trial of early compared with delayed use of inhaled nitric oxide in newborns with a moderate respiratory failure and pulmonary hypertension</article-title>
<source/>J Perinatol
          <year>2010</year>
<volume>30</volume>
<fpage>420</fpage>
<lpage>424</lpage>
<pub-id pub-id-type="doi">10.1038/jp.2009.171</pub-id>
<pub-id pub-id-type="pmid">19890345</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Austin</surname>
<given-names>ED</given-names>
</name>
<name>
<surname>Loyd</surname>
<given-names>JE</given-names>
</name>
</person-group>
<article-title>The genetics of pulmonary arterial hypertension</article-title>
<source/>Circ Res
          <year>2014</year>
<volume>115</volume>
<fpage>189</fpage>
<lpage>202</lpage>
<pub-id pub-id-type="doi">10.1161/CIRCRESAHA.115.303404</pub-id>
<pub-id pub-id-type="pmid">24951767</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mei</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>EDN1 gene variant is associated with neonatal persistent pulmonary hypertension</article-title>
<source/>Sci Rep
          <year>2016</year>
<volume>6</volume>
<fpage>29877</fpage>
<pub-id pub-id-type="doi">10.1038/srep29877</pub-id>
<pub-id pub-id-type="pmid">27425626</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Mei</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>Identification of genetic factors underlying persistent pulmonary hypertension of newborns in a cohort of Chinese neonates</article-title>
<source/>Respir Res
          <year>2019</year>
<volume>20</volume>
<fpage>174</fpage>
<pub-id pub-id-type="doi">10.1186/s12931-019-1148-1</pub-id>
<pub-id pub-id-type="pmid">31382961</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Niermeyer</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Shanmina</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Zhuang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Moore</surname>
<given-names>LG</given-names>
</name>
</person-group>
<article-title>Arterial oxygen saturation in Tibetan and Han infants born in Lhasa, Tibet</article-title>
<source/>N Engl J Med
          <year>1995</year>
<volume>333</volume>
<fpage>1248</fpage>
<lpage>1252</lpage>
<pub-id pub-id-type="doi">10.1056/NEJM199511093331903</pub-id>
<pub-id pub-id-type="pmid">7566001</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bigham</surname>
<given-names>AW</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>FS</given-names>
</name>
</person-group>
<article-title>Human high-altitude adaptation: forward genetics meets the HIF pathway</article-title>
<source/>Genes Dev
          <year>2014</year>
<volume>28</volume>
<fpage>2189</fpage>
<lpage>2204</lpage>
<pub-id pub-id-type="doi">10.1101/gad.250167.114</pub-id>
<pub-id pub-id-type="pmid">25319824</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>S</given-names>
</name>
<name>
<surname>He</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Whole Exome Sequencing Revealed Clinical Relevant Variants in A Family Affected with Autism Spectrum Disorder</article-title>
<source/>J Psychiatry Brain Sci
          <year>2016</year>
<volume>1</volume>
<fpage>3</fpage>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yi</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Huerta-Sanchez</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Cuo</surname>
<given-names>ZX</given-names>
</name>
<name>
<surname>Pool</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Vinckenbosch</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Korneliussen</surname>
<given-names>TS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Sequencing of 50 human exomes reveals adaptation to high altitude</article-title>
<source/>Science
          <year>2010</year>
<volume>329</volume>
<fpage>75</fpage>
<lpage>78</lpage>
<pub-id pub-id-type="doi">10.1126/science.1190371</pub-id>
<pub-id pub-id-type="pmid">20595611</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>ZS</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>RRBS-analyser: a comprehensive web server for reduced representation bisulfite sequencing data analysis</article-title>
<source/>Hum Mutat
          <year>2013</year>
<volume>34</volume>
<fpage>1606</fpage>
<lpage>1610</lpage>
<pub-id pub-id-type="doi">10.1002/humu.22444</pub-id>
<pub-id pub-id-type="pmid">24106010</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bolger</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Lohse</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Usadel</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Trimmomatic: a flexible trimmer for Illumina sequence data</article-title>
<source/>Bioinformatics
          <year>2014</year>
<volume>30</volume>
<fpage>2114</fpage>
<lpage>2120</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/btu170</pub-id>
<pub-id pub-id-type="pmid">24695404</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Toward better understanding of artifacts in variant calling from high-coverage samples</article-title>
<source/>Bioinformatics
          <year>2014</year>
<volume>30</volume>
<fpage>2843</fpage>
<lpage>2851</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/btu356</pub-id>
<pub-id pub-id-type="pmid">24974202</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Detection, annotation and visualization of alternative splicing from RNA-Seq data with SplicingViewer</article-title>
<source/>Genomics
          <year>2012</year>
<volume>99</volume>
<fpage>178</fpage>
<lpage>182</lpage>
<pub-id pub-id-type="doi">10.1016/j.ygeno.2011.12.003</pub-id>
<pub-id pub-id-type="pmid">22226708</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McKenna</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hanna</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Banks</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Sivachenko</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Cibulskis</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kernytsky</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Garimella</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Altshuler</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Gabriel</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Daly</surname>
<given-names>M</given-names>
</name>
<name>
<surname>DePristo</surname>
<given-names>MA</given-names>
</name>
</person-group>
<article-title>The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data</article-title>
<source/>Genome Res
          <year>2010</year>
<volume>20</volume>
<fpage>1297</fpage>
<lpage>1303</lpage>
<pub-id pub-id-type="doi">10.1101/gr.107524.110</pub-id>
<pub-id pub-id-type="pmid">20644199</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hakonarson</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data</article-title>
<source/>Nucleic Acids Res
          <year>2010</year>
<volume>38</volume>
<fpage>e164</fpage>
<pub-id pub-id-type="doi">10.1093/nar/gkq603</pub-id>
<pub-id pub-id-type="pmid">20601685</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ogata</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Goto</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Fujibuchi</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Bono</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kanehisa</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>KEGG: Kyoto encyclopedia of genes and genomes</article-title>
<source/>Nucleic Acids Res
          <year>1999</year>
<volume>27</volume>
<fpage>29</fpage>
<lpage>34</lpage>
<pub-id pub-id-type="doi">10.1093/nar/27.1.29</pub-id>
<pub-id pub-id-type="pmid">9847135</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Mei</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A large-scale screen for coding variants predisposing to psoriasis</article-title>
<source/>Nat Genet
          <year>2014</year>
<volume>46</volume>
<fpage>45</fpage>
<lpage>50</lpage>
<pub-id pub-id-type="doi">10.1038/ng.2827</pub-id>
<pub-id pub-id-type="pmid">24212883</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Robinson</surname>
<given-names>PN</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Phenolyzer: phenotype-based prioritization of candidate genes for human diseases</article-title>
<source/>Nat Methods
          <year>2015</year>
<volume>12</volume>
<fpage>841</fpage>
<lpage>843</lpage>
<pub-id pub-id-type="doi">10.1038/nmeth.3484</pub-id>
<pub-id pub-id-type="pmid">26192085</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Semenza</surname>
<given-names>GL</given-names>
</name>
</person-group>
<article-title>Targeting HIF-1 for cancer therapy</article-title>
<source/>Nat Rev Cancer
          <year>2003</year>
<volume>3</volume>
<fpage>721</fpage>
<lpage>732</lpage>
<pub-id pub-id-type="doi">10.1038/nrc1187</pub-id>
<pub-id pub-id-type="pmid">13130303</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Chohan</surname>
<given-names>IS</given-names>
</name>
</person-group>
<article-title>Blood coagulation changes at high altitude predisposing to pulmonary hypertension</article-title>
<source/>Br Heart J
          <year>1972</year>
<volume>34</volume>
<fpage>611</fpage>
<lpage>617</lpage>
<pub-id pub-id-type="doi">10.1136/hrt.34.6.611</pub-id>
<pub-id pub-id-type="pmid">5040260</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scherrer</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Turini</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Thalmann</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hutter</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Salmon</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Stuber</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Shaw</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Jayet</surname>
<given-names>PY</given-names>
</name>
<name>
<surname>Sartori-Cucchial</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Villena</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Pulmonary hypertension in high-altitude dwellers: novel mechanisms, unsuspected predisposing factors</article-title>
<source/>Adv Exp Med Biol
          <year>2006</year>
<volume>588</volume>
<fpage>277</fpage>
<lpage>291</lpage>
<pub-id pub-id-type="doi">10.1007/978-0-387-34817-9_23</pub-id>
<pub-id pub-id-type="pmid">17089896</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Negi</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Marwaha</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Asotra</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kandoria</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ganju</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>RV</given-names>
</name>
<name>
<surname>Bhardwaj</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Prevalence of high altitude pulmonary hypertension among the natives of Spiti Valley--a high altitude region in Himachal Pradesh, India</article-title>
<source/>High Alt Med Biol
          <year>2014</year>
<volume>15</volume>
<fpage>504</fpage>
<lpage>510</lpage>
<pub-id pub-id-type="doi">10.1089/ham.2013.1112</pub-id>
<pub-id pub-id-type="pmid">25531464</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mirrakhimov</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Strohl</surname>
<given-names>KP</given-names>
</name>
</person-group>
<article-title>High-altitude pulmonary hypertension: an update on disease pathogenesis and management</article-title>
<source/>Open Cardiovasc Med J
          <year>2016</year>
<volume>10</volume>
<fpage>19</fpage>
<lpage>27</lpage>
<pub-id pub-id-type="doi">10.2174/1874192401610010019</pub-id>
<pub-id pub-id-type="pmid">27014374</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>XQ</given-names>
</name>
<name>
<surname>Jing</surname>
<given-names>ZC</given-names>
</name>
</person-group>
<article-title>High-altitude pulmonary hypertension</article-title>
<source/>Eur Respir Rev
          <year>2009</year>
<volume>18</volume>
<fpage>13</fpage>
<lpage>17</lpage>
<pub-id pub-id-type="doi">10.1183/09059180.00011104</pub-id>
<pub-id pub-id-type="pmid">20956117</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Erck</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Frank</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Wehland</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Tubulin-tyrosine ligase, a long-lasting enigma</article-title>
<source/>Neurochem Res
          <year>2000</year>
<volume>25</volume>
<fpage>5</fpage>
<lpage>10</lpage>
<pub-id pub-id-type="doi">10.1023/A:1007523028834</pub-id>
<pub-id pub-id-type="pmid">10685598</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rogowski</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Juge</surname>
<given-names>F</given-names>
</name>
<name>
<surname>van Dijk</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wloga</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Strub</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Levilliers</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Bre</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Van Dorsselaer</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gaertig</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Janke</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Evolutionary divergence of enzymatic mechanisms for posttranslational polyglycylation</article-title>
<source/>Cell
          <year>2009</year>
<volume>137</volume>
<fpage>1076</fpage>
<lpage>1087</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2009.05.020</pub-id>
<pub-id pub-id-type="pmid">19524510</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stones</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Benoist</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Peckham</surname>
<given-names>M</given-names>
</name>
<name>
<surname>White</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Microtubule proliferation in right ventricular myocytes of rats with monocrotaline-induced pulmonary hypertension</article-title>
<source/>J Mol Cell Cardiol
          <year>2013</year>
<volume>56</volume>
<fpage>91</fpage>
<lpage>96</lpage>
<pub-id pub-id-type="doi">10.1016/j.yjmcc.2012.12.010</pub-id>
<pub-id pub-id-type="pmid">23261965</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Schaedel</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Portran</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Aguilar</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gaillard</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Marinkovich</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Thery</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nachury</surname>
<given-names>MV</given-names>
</name>
</person-group>
<article-title>Microtubules acquire resistance from mechanical breakage through intralumenal acetylation</article-title>
<source/>Science
          <year>2017</year>
<volume>356</volume>
<fpage>328</fpage>
<lpage>332</lpage>
<pub-id pub-id-type="doi">10.1126/science.aai8764</pub-id>
<pub-id pub-id-type="pmid">28428427</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schumacher</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Lemke</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Helma</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gerszonowicz</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Waller</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Stoschek</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Durkin</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Budisa</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Leonhardt</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Keller</surname>
<given-names>BG</given-names>
</name>
<name>
<surname>Hackenberger</surname>
<given-names>CPR</given-names>
</name>
</person-group>
<article-title>Broad substrate tolerance of tubulin tyrosine ligase enables one-step site-specific enzymatic protein labeling</article-title>
<source/>Chem Sci
          <year>2017</year>
<volume>8</volume>
<fpage>3471</fpage>
<lpage>3478</lpage>
<pub-id pub-id-type="doi">10.1039/C7SC00574A</pub-id>
<pub-id pub-id-type="pmid">28507719</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garnham</surname>
<given-names>CP</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Roll-Mecak</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Crystal structure of tubulin tyrosine ligase-like 3 reveals essential architectural elements unique to tubulin monoglycylases</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2017</year>
<volume>114</volume>
<fpage>6545</fpage>
<lpage>6550</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1617286114</pub-id>
<pub-id pub-id-type="pmid">28576883</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Garnham</surname>
<given-names>CP</given-names>
</name>
<name>
<surname>Roll-Mecak</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Writing and Reading the tubulin code</article-title>
<source/>J Biol Chem
          <year>2015</year>
<volume>290</volume>
<fpage>17163</fpage>
<lpage>17172</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.R115.637447</pub-id>
<pub-id pub-id-type="pmid">25957412</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garnham</surname>
<given-names>CP</given-names>
</name>
<name>
<surname>Vemu</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wilson-Kubalek</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Szyk</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lander</surname>
<given-names>GC</given-names>
</name>
<name>
<surname>Milligan</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Roll-Mecak</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Multivalent microtubule recognition by tubulin tyrosine ligase-like family Glutamylases</article-title>
<source/>Cell
          <year>2015</year>
<volume>161</volume>
<fpage>1112</fpage>
<lpage>1123</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2015.04.003</pub-id>
<pub-id pub-id-type="pmid">25959773</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Valenstein</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Roll-Mecak</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Graded control of microtubule severing by tubulin Glutamylation</article-title>
<source/>Cell
          <year>2016</year>
<volume>164</volume>
<fpage>911</fpage>
<lpage>921</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2016.01.019</pub-id>
<pub-id pub-id-type="pmid">26875866</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fediuk</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sikarwar</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Nolette</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Dakshinamurti</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Thromboxane-induced actin polymerization in hypoxic neonatal pulmonary arterial myocytes involves Cdc42 signaling</article-title>
<source/>Am J Phys Lung Cell Mol Phys
          <year>2014</year>
<volume>307</volume>
<fpage>L877</fpage>
<lpage>L887</lpage>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fediuk</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gutsol</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Nolette</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Dakshinamurti</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Thromboxane-induced actin polymerization in hypoxic pulmonary artery is independent of rho</article-title>
<source/>Am J Phys Lung Cell Mol Phys
          <year>2012</year>
<volume>302</volume>
<fpage>L13</fpage>
<lpage>L26</lpage>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Umesh</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Paudel</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>YN</given-names>
</name>
<name>
<surname>Myers</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Sham</surname>
<given-names>JS</given-names>
</name>
</person-group>
<article-title>Alteration of pulmonary artery integrin levels in chronic hypoxia and monocrotaline-induced pulmonary hypertension</article-title>
<source/>J Vasc Res
          <year>2011</year>
<volume>48</volume>
<fpage>525</fpage>
<lpage>537</lpage>
<pub-id pub-id-type="doi">10.1159/000329593</pub-id>
<pub-id pub-id-type="pmid">21829038</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Jesus Perez</surname>
<given-names>VA</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Orcholski</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Sawada</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>CG</given-names>
</name>
<name>
<surname>Tojais</surname>
<given-names>NF</given-names>
</name>
<name>
<surname>Nickel</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Rajagopalan</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Spiekerkoetter</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Loss of adenomatous poliposis coli-alpha3 integrin interaction promotes endothelial apoptosis in mice and humans</article-title>
<source/>Circ Res
          <year>2012</year>
<volume>111</volume>
<fpage>1551</fpage>
<lpage>1564</lpage>
<pub-id pub-id-type="doi">10.1161/CIRCRESAHA.112.267849</pub-id>
<pub-id pub-id-type="pmid">23011394</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Shao</surname>
<given-names>NY</given-names>
</name>
<name>
<surname>Sa</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Termglinchan</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Ameen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Karakikes</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Sosa</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Grubert</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Patient-specific iPSC-derived endothelial cells uncover pathways that protect against pulmonary hypertension in BMPR2 mutation carriers</article-title>
<source/>Cell Stem Cell
          <year>2017</year>
<volume>20</volume>
<fpage>490</fpage>
<lpage>504</lpage>
<pub-id pub-id-type="doi">10.1016/j.stem.2016.08.019</pub-id>
<pub-id pub-id-type="pmid">28017794</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xiao</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Takagi</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Coller</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Springer</surname>
<given-names>TA</given-names>
</name>
</person-group>
<article-title>Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics</article-title>
<source/>Nature
          <year>2004</year>
<volume>432</volume>
<fpage>59</fpage>
<lpage>67</lpage>
<pub-id pub-id-type="doi">10.1038/nature02976</pub-id>
<pub-id pub-id-type="pmid">15378069</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>XH</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>ZS</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>LJ</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>YZ</given-names>
</name>
<name>
<surname>Ouyang</surname>
<given-names>HW</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Platelet-mediated mesenchymal stem cells homing to the lung reduces monocrotaline-induced rat pulmonary hypertension</article-title>
<source/>Cell Transplant
          <year>2012</year>
<volume>21</volume>
<fpage>1463</fpage>
<lpage>1475</lpage>
<pub-id pub-id-type="doi">10.3727/096368912X640529</pub-id>
<pub-id pub-id-type="pmid">22525351</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Erhardt</surname>
<given-names>PW</given-names>
</name>
<name>
<surname>Pavlovsky</surname>
<given-names>A</given-names>
</name>
<name>
<surname>AS</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Bledzka</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ustinov</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Leukocyte integrin mac-1 regulates thrombosis via interaction with platelet GPIbalpha</article-title>
<source/>Nat Commun
          <year>2017</year>
<volume>8</volume>
<fpage>15559</fpage>
<pub-id pub-id-type="doi">10.1038/ncomms15559</pub-id>
<pub-id pub-id-type="pmid">28555620</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lafyatis</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Transforming growth factor beta--at the Centre of systemic sclerosis</article-title>
<source/>Nat Rev Rheumatol
          <year>2014</year>
<volume>10</volume>
<fpage>706</fpage>
<lpage>719</lpage>
<pub-id pub-id-type="doi">10.1038/nrrheum.2014.137</pub-id>
<pub-id pub-id-type="pmid">25136781</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Welschoff</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Matthey</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wenzel</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>RGD peptides induce relaxation of pulmonary arteries and airways via beta3-integrins</article-title>
<source/>FASEB J
          <year>2014</year>
<volume>28</volume>
<fpage>2281</fpage>
<lpage>2292</lpage>
<pub-id pub-id-type="doi">10.1096/fj.13-246348</pub-id>
<pub-id pub-id-type="pmid">24500921</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kawaguchi</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Yoshihara</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hayama</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Furutani</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kawaguchi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Nakanishi</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Silibinin efficacy in a rat model of pulmonary arterial hypertension using monocrotaline and chronic hypoxia</article-title>
<source/>Respir Res
          <year>2019</year>
<volume>20</volume>
<fpage>79</fpage>
<pub-id pub-id-type="doi">10.1186/s12931-019-1041-y</pub-id>
<pub-id pub-id-type="pmid">31023308</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Guan</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>YM</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Chronic intermittent hypobaric hypoxia ameliorates renal vascular hypertension through up-regulating NOS in nucleus Tractus Solitarii</article-title>
<source/>Neurosci Bull
          <year>2019</year>
<volume>35</volume>
<fpage>79</fpage>
<lpage>90</lpage>
<pub-id pub-id-type="doi">10.1007/s12264-018-00330-z</pub-id>
<pub-id pub-id-type="pmid">30617765</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>